Published in
Taylor and Francis Group, Leukemia & Lymphoma, 7(63), p. 1723-1727, 2022
DOI: 10.1080/10428194.2022.2038377
Links
Tools
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience
Journal article published in 2022 by
Neha Mehta-Shah 
,
Nancy L. Bartlett ,
Marcus P. Watkins ,
Bartlett Nl,
Brad Kahl,
Watkins Mp,
Amalia Dubois,
Gabby Schmelzle,
Saiama Waqar,
Claire Ballman,
Fei Wan,
Farnsworth Cw,
Christopher W. Farnsworth
,
Nancy L. Bartlett ,
Marcus P. Watkins ,
Bartlett Nl,
Brad Kahl,
Watkins Mp,
Amalia Dubois,
Gabby Schmelzle,
Saiama Waqar,
Claire Ballman,
Fei Wan,
Farnsworth Cw,
Christopher W. Farnsworth
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 